BOSTON, Oct. 23, 2024 /PRNewswire/ — Nemdx, Inc. today announced a poster presentation at the 2024 Northeast ALS Annual Conference (NEALS) hosted online on October 21-24. The poster, presented by Vito Levi D’Ancona, president of Nemdx, will feature amyotrophic lateral sclerosis (ALS) research, including findings from testing over 300 samples from multiple biorepositories provided by MGH, NIH/NINDS, Spedali Civili di Brescia, and UK draws.
Dr. Ghazaleh Sadri-Vakili, Director of the NeuroEpigenetics Laboratory at Massachusetts General Hospital and co-author of the poster commented, “The findings presented by Nemdx offer a promising new direction in ALS biomarker research. Their innovative approach to measuring TDP-43 function could significantly impact our ability to diagnose and monitor ALS progression.”